Inactivation of Smad5 in endothelial cells and smooth muscle cells demonstrates that Smad5 is required for cardiac homeostasis

American Journal of Pathology

Volumn 170, Issue 5, 2007, Pages 1460-1472

  Umans, Lieve ^a,b   Cox, Luk ^a,b   Tjwa, Marc ^a,b   Bito, Virginie ^c   Vermeire, Liesbeth ^a,b   Laperre, Kjell ^a,b   Sipido, Karin ^c   Moons, Lieve ^a,b   Huylebroeck, Danny ^a,b   Zwijsen, An ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; SMAD5 PROTEIN; TIE 1 RECEPTOR; VASCULOTROPIN; SMAD5 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; TREADMILL; VASCULARIZATION; ANIMAL; BLOOD VESSEL; CYTOLOGY; EMBRYO; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE MUTANT; NEWBORN; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; BLOOD VESSELS; ECHOCARDIOGRAPHY; EMBRYO; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HEART; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; SMAD5 PROTEIN;

EID: 34250844456     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060839     Document Type: Article

References (46)

1. Attisano L, Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000, 12:235-243
2. ten Dijke P, Goumans MJ, Itoh F, Itoh S: Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002, 191:1-16
3. Verschueren K, Huylebroeck D: Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells. Cytokine Growth Factor Rev 1999, 10:187-199
4. Bruno E, Horrigan SK, Van Den Berg D, Rozler E, Fitting PR, Moss ST, Westbrook C, Hoffman R: The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 1998, 91:1917-1923
5. Goumans MJ, Mummery C: Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 2000, 44:253-265
6. Bertolino P, Deckers M, Lebrin F, ten Dijke P: Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 2005, 128:585S-590S
7. Park C, Lavine K, Mishina Y, Deng CX, Ornitz DM, Choi K: Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development 2006, 133:3473-3484
8. Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM, Zwijsen A: Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 1999, 126:1631-1642
9. Yang X, Castilla LH, Xu X, Li C, Gotay J, Weinstein M, Liu PP, Deng CX: Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 1999, 126:1571-1580
10. Lechleider RJ, Ryan JL, Garrett L, Eng C, Deng C, Wynshaw-Boris A, Roberts AB: Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol 2001, 240:157-167
11. Tremblay KD, Dunn NR, Robertson EJ: Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 2001, 128:3609-3621
12. Chang H, Zwijsen A, Vogel H, Huylebroeck D, Matzuk MM: Smad5 is essential for left-right asymmetry in mice. Dev Biol 2000, 219:71-78
13. Hester M, Thompson JC, Mills J, Liu Y, El-Hodiri HM, Weinstein M: Smad1 and Smad8 function similarly in mammalian central nervous system development. Mol Cell Biol 2005, 25:4683-4692
14. Arnold SJ, Maretto S, Islam A, Bikoff EK, Robertson EJ: Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev Biol 2006, 296:104-118
15. van den Driesche S, Mummery CL, Westermann CJ: Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. Cardiovasc Res 2003, 58:20-31
16. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P: Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002, 21:1743-1753
17. Lamouille S, Mallet C, Feige JJ, Bailly S: Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 2002, 100:4495-4501
18. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E: Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 2000, 97:2626-2631
19. Gustafsson E, Brakebusch C, Hietanen K, Fassler R: Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci 2001, 114:671-676
20. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M: Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 2001, 230:230-242
21. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M: Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 2002, 99:7142-7147
22. Umans L, Vermeire L, Francis A, Chang H, Huylebroeck D, Zwijsen A: Generation of a floxed allele of Smad5 for cre-mediated conditional knockout in the mouse. Genesis 2003, 37:5-11
23. Soriano P: Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999, 21:70-71
24. Lodge PA, Haisch CE, Thomas FT: A simple method of vascular endothelial cell isolation. Transplant Proc 1992, 24:2816-2817
25. Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ: Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation 1997, 96:4333-4342
26. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ: A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996, 37:1625-1632
27. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD: Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 2004, 94:1256-1262
28. Antoons G, Mubagwa K, Nevelsteen I, Sipido KR: Mechanisms underlying the frequency dependence of contraction and [Ca(2+)](i) transients in mouse ventricular myocytes. J Physiol 2002, 543:889-898
29. Zhang JC, Kim S, Helmke BP, Yu WW, Du KL, Lu MM, Strobeck M, Yu Q, Parmacek MS: Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol 2001, 21:1336-1344
30. Gaussin V, Van de Putte T, Mishina Y, Hanks MC, Zwijsen A, Huylebroeck D, Behringer RR, Schneider MD: Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci USA 2002, 99:2878-2883
31. Brawn MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, Singh M, TsarevaT, Parice Y, Mahoney A, Roschke V, Sanyal I, Choe S: Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 2005, 280:25111-25118
32. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S: Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) endothelial cells. Blood 2007, 109:1953-1961
33. Pontén A, Li X, Thoren P, Aase K, Sjoblom T, Ostman A, Eriksson U: Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am J Pathol 2003, 163:673-682
34. Zwijsen A, van Grunsven LA, Bosman EA, Collart C, Nelles L, Umans L, Van de Putte T, Wuytens G, Huylebroeck D, Verschueren K: Transforming growth factor beta signalling in vitro and in vivo: activin ligand-receptor interaction, Smad5 in vasculogenesis, and repression of target genes by the deltaEF1/ZEB-related SIP1 in the vertebrate embryo. Mol Cell Endocrinol 2001, 180:13-24
35. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P: Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 2004, 23:4018-4028
36. Pece-Barbara N, Vera S, Kathirkamathamby K, Liebner S, Di Guglielmo GM, Dejana E, Wrana JL, Letarte M: Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. J Biol Chem 2005, 280:27800-27808
37. Frutkin AD, Shi H, Otsuka G, Leveen P, Karlsson S, Dichek DA: A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre. J Mol Cell Cardiol 2006, 41:724-731
38. Li L, Miano JM, Cserjesi P, Olson EN: SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 1996, 78:188-195
39. Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA: Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 2002, 53:709-719
40. Du XJ: Gender modulates cardiac phenotype development in genetically modified mice. Cardiovasc Res 2004, 63:510-519
41. Enge M, Bjarnegard M, Gerhardt H, Gustafsson E, Kalen M, Asker N, Hammes HP, Shani M, Fassler R, Betsholtz C: Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J 2002, 21:4307-4316
42. Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, Dijke PT, Arthur HM, Mummery CL: Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 2004, 131:6237-6247
43. Flanders KC, Kim ES, Roberts AB: Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas. Dev Dyn 2001, 220:141-154
44. Chang H, Matzuk MM: Smad5 is required for mouse primordial germ cell development. Mech Dev 2001, 104:61-67
45. Bosman EA, Lawson KA, Debruyn J, Beek L, Francis A, Schoonjans L, Huylebroeck D, Zwijsen A: Smad5 determines murine amnion fate through the control of bone morphogenetic protein expression and signalling levels. Development 2006, 133:3399-3409
46. Singbrant S, Moody JL, Blank U, Karlsson G, Umans L, Zwijsen A, Karlsson S: Smad5 is dispensable for adult murine hematopoiesis. Blood 2006, 108:3707-3712